Anticipate generic drug launch
Proactively manage your pharmacy inventory
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Drug patents …
… from Kazakhstan to Kalamazoo
Manage your formulary budget
|Title:||Human growth hormone aqueous formulation|
|Abstract:||A stable pharmaceutically acceptable aqueous formulation containing human growth hormone, a buffer, a non-ionic surfactant, and, optionally, a neutral salt, mannitol, or, a preservative, is disclosed. Also disclosed are associated means and methods for preparing, storing, and using such formulations.|
|Inventor(s):||O'Connor; Barbara H. (San Carlos, CA), Oeswein; James Q. (Moss Beach, CA)|
|Assignee:||Genentech, Inc. (South San Francisco, CA)|
Patent Claim Types:|
see list of patent claims
|Formulation; Compound; Use;|
|PCT Filed||July 29, 1993||PCT Application Number:||PCT/US93/07149|
|PCT Publication Date:||February 17, 1994||PCT Publication Number:||WO94/03198|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.